These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 15963101)

  • 1. Association between CYP2C9 slow metabolizer genotypes and severe hypoglycaemia on medication with sulphonylurea hypoglycaemic agents.
    Holstein A; Plaschke A; Ptak M; Egberts EH; El-Din J; Brockmöller J; Kirchheiner J
    Br J Clin Pharmacol; 2005 Jul; 60(1):103-6. PubMed ID: 15963101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presence of CYP2C9*3 allele increases risk for hypoglycemia in Type 2 diabetic patients treated with sulfonylureas.
    Ragia G; Petridis I; Tavridou A; Christakidis D; Manolopoulos VG
    Pharmacogenomics; 2009 Nov; 10(11):1781-7. PubMed ID: 19891554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of clinical factors and CYP2C9 variants for the risk of severe sulfonylurea-induced hypoglycemia.
    Holstein A; Hahn M; Patzer O; Seeringer A; Kovacs P; Stingl J
    Eur J Clin Pharmacol; 2011 May; 67(5):471-6. PubMed ID: 21213107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoglycaemia in patients with type 2 diabetes treated with a combination of metformin and sulphonylurea therapy in France.
    Vexiau P; Mavros P; Krishnarajah G; Lyu R; Yin D
    Diabetes Obes Metab; 2008 Jun; 10 Suppl 1():16-24. PubMed ID: 18435670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CYP2C9*2 allele increases risk for hypoglycemia in POR*1/*1 type 2 diabetic patients treated with sulfonylureas.
    Ragia G; Tavridou A; Elens L; Van Schaik RH; Manolopoulos VG
    Exp Clin Endocrinol Diabetes; 2014 Jan; 122(1):60-3. PubMed ID: 24464600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mild hypoglycaemic attacks induced by sulphonylureas related to CYP2C9, CYP2C19 and CYP2C8 polymorphisms in routine clinical setting.
    Gökalp O; Gunes A; Cam H; Cure E; Aydın O; Tamer MN; Scordo MG; Dahl ML
    Eur J Clin Pharmacol; 2011 Dec; 67(12):1223-9. PubMed ID: 21691805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing hormonal and symptomatic responses to experimental hypoglycaemia in insulin- and sulphonylurea-treated Type 2 diabetes.
    Choudhary P; Lonnen K; Emery CJ; MacDonald IA; MacLeod KM; Amiel SA; Heller SR
    Diabet Med; 2009 Jul; 26(7):665-72. PubMed ID: 19573114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Incidence of severe hypoglycemia in relation to metabolic control and patient knowledge].
    Ratzmann KP; Schimke E
    Med Klin (Munich); 1995 Oct; 90(10):557-61. PubMed ID: 7500918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe hypoglycaemia leading to hospital admission in type 2 diabetic patients aged 80 years or older.
    Greco D; Pisciotta M; Gambina F; Maggio F
    Exp Clin Endocrinol Diabetes; 2010 Apr; 118(4):215-9. PubMed ID: 20072965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Worry vs. knowledge about treatment-associated hypoglycaemia and weight gain in type 2 diabetic patients on metformin and/or sulphonylurea.
    Lund A; Knop FK
    Curr Med Res Opin; 2012 May; 28(5):731-6. PubMed ID: 22462528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoglycaemic valleys: an under-recognised problem in type 2 diabetes?
    Frier BM
    Int J Clin Pract Suppl; 2002 Jul; (129):12-9. PubMed ID: 12166599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of CYP2C9 gene polymorphisms on response to glibenclamide in type 2 diabetes mellitus patients.
    Surendiran A; Pradhan SC; Agrawal A; Subrahmanyam DK; Rajan S; Anichavezhi D; Adithan C
    Eur J Clin Pharmacol; 2011 Aug; 67(8):797-801. PubMed ID: 21336994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Higher incidence of severe hypoglycaemia leading to hospital admission in Type 2 diabetic patients treated with long-acting versus short-acting sulphonylureas.
    Stahl M; Berger W
    Diabet Med; 1999 Jul; 16(7):586-90. PubMed ID: 10445835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The E23K variant of KCNJ11 and the risk for severe sulfonylurea-induced hypoglycemia in patients with type 2 diabetes.
    Holstein A; Hahn M; Stumvoll M; Kovacs P
    Horm Metab Res; 2009 May; 41(5):387-90. PubMed ID: 19214942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytochrome P450 2C9 *2 and *3 polymorphisms and the dose and effect of sulfonylurea in type II diabetes mellitus.
    Becker ML; Visser LE; Trienekens PH; Hofman A; van Schaik RH; Stricker BH
    Clin Pharmacol Ther; 2008 Feb; 83(2):288-92. PubMed ID: 17597710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics and time course of severe glimepiride- versus glibenclamide-induced hypoglycaemia.
    Holstein A; Plaschke A; Hammer C; Egberts EH
    Eur J Clin Pharmacol; 2003 Jun; 59(2):91-7. PubMed ID: 12698302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired renal function modifies the risk of severe hypoglycaemia among users of insulin but not glyburide: a population-based nested case-control study.
    Weir MA; Gomes T; Mamdani M; Juurlink DN; Hackam DG; Mahon JL; Jain AK; Garg AX
    Nephrol Dial Transplant; 2011 Jun; 26(6):1888-94. PubMed ID: 20974644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of hypoglycaemia in users of sulphonylureas compared with metformin in relation to renal function and sulphonylurea metabolite group: population based cohort study.
    van Dalem J; Brouwers MC; Stehouwer CD; Krings A; Leufkens HG; Driessen JH; de Vries F; Burden AM
    BMJ; 2016 Jul; 354():i3625. PubMed ID: 27413017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of relapse in elderly diabetic patients admitted with sulphonylurea-induced severe hypoglycaemic attacks.
    Chan TY; Cheung AY
    Age Ageing; 1997 Sep; 26(5):409-10. PubMed ID: 9351488
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug-induced severe hypoglycaemia in Type 2 diabetic patients aged 80 years or older.
    Greco D; Angileri G
    Diabetes Nutr Metab; 2004 Feb; 17(1):23-6. PubMed ID: 15163121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.